283 related articles for article (PubMed ID: 8718519)
1. Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2.
Ponder BA
Cancer Surv; 1995; 25():195-205. PubMed ID: 8718519
[No Abstract] [Full Text] [Related]
2. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
3. The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects.
Beldjord C; Desclaux-Arramond F; Raffin-Sanson M; Corvol JC; De Keyzer Y; Luton JP; Plouin PF; Bertagna X
J Clin Endocrinol Metab; 1995 Jul; 80(7):2063-8. PubMed ID: 7608256
[TBL] [Abstract][Full Text] [Related]
4. Sporadic multiple endocrine neoplasia type 2A.
Yamashita S
Intern Med; 1999 Feb; 38(2):80. PubMed ID: 10225659
[No Abstract] [Full Text] [Related]
5. The RET proto-oncogene in sporadic pheochromocytomas.
Takaya K; Yoshimasa T; Arai H; Tamura N; Miyamoto Y; Itoh H; Nakao K
Intern Med; 1996 Jun; 35(6):449-52. PubMed ID: 8835594
[TBL] [Abstract][Full Text] [Related]
6. Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.
Mulligan LM; Ponder BA
J Clin Endocrinol Metab; 1995 Jul; 80(7):1989-95. PubMed ID: 7608246
[No Abstract] [Full Text] [Related]
7. RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer.
Blaugrund JE; Johns MM; Eby YJ; Ball DW; Baylin SB; Hruban RH; Sidransky D
Hum Mol Genet; 1994 Oct; 3(10):1895-7. PubMed ID: 7849720
[No Abstract] [Full Text] [Related]
8. Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2.
Pausova Z; Soliman E; Amizuka N; Janicic N; Konrad EM; Arnold A; Goltzman D; Hendy GN
J Clin Endocrinol Metab; 1996 Jul; 81(7):2711-8. PubMed ID: 8675600
[TBL] [Abstract][Full Text] [Related]
9. Germ line mutations of the ret proto-oncogene in Japanese patients with multiple endocrine neoplasia type 2A and type 2B.
Maruyama S; Iwashita T; Imai T; Funahashi H; Ceccherini I; Luo Y; Romeo G; Matsuo S; Matsuyama M; Takahashi M
Jpn J Cancer Res; 1994 Sep; 85(9):879-82. PubMed ID: 7961113
[TBL] [Abstract][Full Text] [Related]
10. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes and Hirschsprung disease.
Smith DP; Eng C; Ponder BA
J Cell Sci Suppl; 1994; 18():43-9. PubMed ID: 7883791
[TBL] [Abstract][Full Text] [Related]
11. Multiple endocrine neoplasia type 2.
Forster-Gibson CJ; Mulligan LM
Eur J Cancer; 1994; 30A(13):1969-74. PubMed ID: 7734209
[No Abstract] [Full Text] [Related]
12. Germ line mutation in the RET proto-oncogene associated with familial multiple endocrine neoplasia type 2B: a case report.
Ishida O; Zeki K; Morimoto I; Yamamoto S; Fujihira T; Eto S
Jpn J Clin Oncol; 1995 Jun; 25(3):104-8. PubMed ID: 7596047
[TBL] [Abstract][Full Text] [Related]
13. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.
Eng C; Smith DP; Mulligan LM; Nagai MA; Healey CS; Ponder MA; Gardner E; Scheumann GF; Jackson CE; Tunnacliffe A
Hum Mol Genet; 1994 Feb; 3(2):237-41. PubMed ID: 7911697
[TBL] [Abstract][Full Text] [Related]
14. Composite phaeochromocytoma-ganglioneuroblastoma in a patient with multiple endocrine neoplasia type IIA.
Matias-Guiu X; Garrastazu MT
Histopathology; 1998 Mar; 32(3):281-2. PubMed ID: 9568520
[No Abstract] [Full Text] [Related]
15. Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations.
Rossel M; Pasini A; Chappuis S; Geneste O; Fournier L; Schuffenecker I; Takahashi M; van Grunsven LA; Urdiales JL; Rudkin BB; Lenoir GM; Billaud M
Oncogene; 1997 Jan; 14(3):265-75. PubMed ID: 9018112
[TBL] [Abstract][Full Text] [Related]
16. Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN2A or MEN2B mutation.
Iwashita T; Asai N; Murakami H; Matsuyama M; Takahashi M
Oncogene; 1996 Feb; 12(3):481-7. PubMed ID: 8637703
[TBL] [Abstract][Full Text] [Related]
17. Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation.
Nilsson O; Tisell LE; Jansson S; Ahlman H; Gimm O; Eng C
JAMA; 1999 May; 281(17):1587-8. PubMed ID: 10235148
[No Abstract] [Full Text] [Related]
18. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
Sansó G; Domené HM; Iorcansky S; Barontini M
Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
[TBL] [Abstract][Full Text] [Related]
19. Absence of mutations at codon 768 of the RET proto-oncogene in sporadic and hereditary pheochromocytomas.
Yoshimoto K; Kimura T; Tanaka C; Moritani M; Iwahana H; Itakura M
Endocr J; 1996 Feb; 43(1):109-14. PubMed ID: 8732460
[TBL] [Abstract][Full Text] [Related]
20. Absence of mutations in the MEN2A region of the ret proto-oncogene in non-MEN 2A phaeochromocytomas.
Chew SL; Lavender P; Jain A; Weber A; Ross RJ; Wass JA; Besser GM; Clark AJ
Clin Endocrinol (Oxf); 1995 Jan; 42(1):17-21. PubMed ID: 7889627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
